GGrantIndex
Sort

51,593 grants matching hepatitis

Novel Mechanisms Regulating the Adipocyte-Brain Hepatocyte Axis

$1,430,469
Philipp E Scherer · Ut Southwestern Medical Center · P01 · FY2013 · DK

The Southernearch Center for ALPD and Cirrhosis

$1,430,434
Hidekazu Tsukamoto · University Of Southern California · P50 · FY2023 · AA

A Pilot Clinical Study in Acute STEMI

$1,430,128
Weizhong Cai · Angion Biomedica Corporation · R44 · FY2010 · HL

SIGNALING PATHWAYS IN CONTROL OF GROWTH AND DEVELOPMENT

$1,430,003
Alan R Kimmel · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK

Proteomics Core

$1,429,568
Elizabeth Murphy · National Heart, Lung, And Blood Institute · ZIC · FY2011 · HL

Epilepsy Clinical Research Program

$1,429,121
University Of Minnesota Twin Cities · P50 · FY2003 · NS

International Center for Excellence in Research (ICER) in Uganda: Impact of ARVs

$1,428,469
Thomas Quinn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI

Cardiovascular Inflammation Reduction Trial (CIRT): DCC

$1,428,182
Robert J Glynn · Brigham And Women'S Hospital · U01 · FY2015 · HL

Personalized prime editing as a platform for hepatic inborn errors of metabolism

$1,427,560
Rebecca Clare Ahrens-Nicklas · Children'S Hosp Of Philadelphia · U01 · FY2025 · TR

DEVELOPMENT OF NOVEL THERAPIES FOR NIDDM

$1,426,644
University Of Texas Sw Med Ctr/Dallas · P01 · FY2000 · DK

Safety and PK Study in Hepatic Impairment Patients

$1,426,068
Weizhong Cai · Angion Biomedica Corporation · R44 · FY2009 · AA

Physiology, Psychology, and Genetics of Obesity

$1,425,532
Jack A. Yanovski · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2020 · HD

Liver Cancer Control Interventions for Asian Americans

$1,424,275
Moon S Chen · University Of California At Davis · P01 · FY2009 · CA

Regulation of Liver by Nuclear Ca2+ Signaling

$1,424,224
Michael H Nathanson · Yale University · P01 · FY2013 · DK

Nuclear receptors: action, functions, and roles in disease

$1,424,077
Anton M Jetten · National Institute Of Environmental Health Sciences · ZIA · FY2010 · ES

HIV Treatment in the homeless: a prospective study

$1,423,808
University Of California San Francisco · R01 · FY2003 · MH

Stellenbosch University Clinical Trial Unit, Cape Town, South Africa

$1,422,798
Mark Fredric Cotton · Stellenbosch University · U01 · FY2009 · AI

Mechanisms of Therapy and Model Development in Viral Hepatitis and Liver Diseases

$1,422,712
T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK

The Role of HLA and KIR in Rheumatoid Arthritis and Crohn's Disease

$1,422,674
Henry A Erlich · Children'S Hospital & Res Ctr At Oakland · U01 · FY2009 · AI

Reinvigorating HIV Prevention and Care for People Who Use Drugs: Accelerating Progress and Sustaining Gains in the Midst of Societal Disruption

$1,422,599
Don C Des Jarlais · New York University · P30 · FY2024 · DA

DEVELOPMENT OF NOVEL THERAPIES FOR NIDDM

$1,421,967
University Of Texas Sw Med Ctr/Dallas · P01 · FY2001 · DK

Phosphoinositide-calcium Signaling In Cell Regulation

$1,421,412
Tamas Balla · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2011 · HD

A novel diagnostic Kit for Hepatocellular Carcinoma

$1,420,847
Xuanyong Lu · Imcare Biotech, Inc. · R44 · FY2021 · CA

MOLECULAR BIOLOGY AND GENETICS OF TUMOR VIRUSES

$1,420,495
University Of Wisconsin Madison · P01 · FY2001 · CA

ANIMAL MODEL EVALUATION OF CANDIDATE HEPATITIS THERAPIES

$1,420,336
Cornell University Ithaca · N01 · FY2000 · AI